Protalix BioTherapeutics, Inc.
PLX • AMEX • Stock Fundamentals
Protalix BioTherapeutics, Inc. is a biotechnology company in the healthcare sector trading on AMEX, led by CEO Dror Bashan, with a market cap of $172.4M.
Market Cap$172.4M
Employees208.0
CEODror Bashan
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 13, 2026 · 15 days agoQ1 2026
View reportNext EarningsAug 13, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Protalix BioTherapeutics, Inc. FAQ
Common questions about Protalix BioTherapeutics, Inc.
Protalix BioTherapeutics, Inc. (PLX) has a market capitalization of $172.4M and trades on AMEX.
Protalix BioTherapeutics, Inc. has approximately 208 employees.